297 filings
10-Q
2024 Q1
SLRX
Salarius Pharmaceuticals Inc
Quarterly report
13 May 24
4:17pm
DEFA14A
SLRX
Salarius Pharmaceuticals Inc
26 Mar 24
Additional proxy soliciting materials
4:05pm
DEF 14A
SLRX
Salarius Pharmaceuticals Inc
Definitive proxy
26 Mar 24
4:03pm
10-K
2023 FY
SLRX
Salarius Pharmaceuticals Inc
Annual report
22 Mar 24
4:12pm
DFAN14A
n8gxjyxg
19 Mar 24
Additional proxy materials by non-management
7:39pm
8-K
9t0xpp5gq9 erlva
6 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
7z3der d27b0
22 Feb 24
Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses
5:55pm
8-K
qwg3mievnjifpg ao8u0
6 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:09pm
8-K
mo9q iiwavh
10 Aug 23
Salarius Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:14pm
8-K
qgff54eklapj5fdsqbpz
12 Jul 23
Other Events
9:22am
8-K
l8cpc6vc n75
14 Jun 23
Departure of Directors or Certain Officers
6:47pm
EFFECT
vi4o41t85k1ligo3zdv
8 Jun 23
Notice of effectiveness
12:15am
424B3
czp397lhuruk l903l7
7 Jun 23
Prospectus supplement
7:27am
CORRESP
xfc9 pmjl
2 Jun 23
Correspondence with SEC
12:00am
UPLOAD
ml358lwrnx9snh
1 Jun 23
Letter from SEC
12:00am